Earnings ·
Organigram Global Inc. reported net revenue of CAD 105.8 million for Q3 Fiscal 2026, a 49% increase from the prior…
OGIOrganigram Global Inc.
Organigram Global Inc. reported net revenue of CAD 105.8 million for Q3 Fiscal 2026, a 49% increase from the prior year period, driven by the acquisition of Sanity Group and domestic recreational sales growth. The company posted net income of CAD 105.5 million, primarily due to a CAD 105.8 million fair value gain on Preferred Shares issued to British American Tobacco (BAT), which increased its ownership to approximately 48%. Adjusted EBITDA rose 136% to CAD 13.4 million. The company also recognized a CAD 5.8 million impairment charge related to its U.S. hemp-derived products business, which is being wound down due to regulatory changes effective November 2026. Organigram operates in the cannabis industry, cultivating and producing consumer packaged goods containing cannabis for domestic and international markets.